Consensus Alpine 4 Holdings, Inc.

Equities

ALPP

US02083E2046

Delayed Nasdaq Other stock markets 11:06:32 2024-05-07 EDT			5-day change	1st Jan Change
0.8006 ^USD	+6.75%		+3.84%	+8.93%

2023	NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint	MT
2023	Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index	CI

Evolution of the average Target Price on Alpine 4 Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9a3ac6849b63de8948.0QeRt9qHZzMgbpbseiMRJridWLbLcbzFr4OUo5Q1-VE.iUz8_JX2KEBZKaS4LVRoH9vwCezzQsazzOX9mvl9sA62dqGEi7AqWEECww~00aaa0c0c5e1f31a30741697cc42aa9f

Analyst Recommendations on Alpine 4 Holdings, Inc.

Alliance Global Starts Alpine 4 Holdings at Buy With $2.75 Price Target

22-08-23

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.75 USD

Average target price

2.25 USD

Spread / Average Target

+200.00%

High Price Target

2.25 USD

Spread / Highest target

+200.00%

Low Price Target

2.25 USD

Spread / Lowest Target

+200.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alpine 4 Holdings, Inc.

Alliance Global Partners

Quarterly revenue - Rate of surprise

Company calendar